Login to Your Account

Bench Press: BioWorld Looks at Translational Medicine

Monday, August 19, 2013
Scientists at the University of Texas Health Science Center at San Antonio have discovered why amplifications of certain parts of chromosomes 17 and 20 are associated with a poor prognosis in breast cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription